Compare Mesoblast Limited (MESO) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Occidental Petroleum Corporation — how do they compare? Mesoblast Limited trades at $14.28 (market cap $1.75B), while Occidental Petroleum Corporation trades at $60.58 (market cap $60.26B). The key difference: Occidental Petroleum Corporation is far larger — about 34.4× Mesoblast Limited's market cap, and Occidental Petroleum Corporation pays a 1.86% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mesoblast Limited for 15 Days and Occidental Petroleum Corporation for 92 Days on average.
| MESO | OXY | |
|---|---|---|
Market Cap | $1.75B | $60.26B |
Volume | 239,027 | 11,718,920 |
Sector | Health | Energy |
52-Week High | $20.96 | $66.24 |
52-Week Low | $13.19 | $38.92 |
Typical Hold Time | 15 Days | 92 Days |
Enterprise Value | $1.83B | $79.02B |
Dividend Yield | — | 1.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MESO trades at $13.94, up 2.42% with bearish technical signals from moving averages. The company reported substantial revenue growth to $120 million in 2026 but remains unprofitable with a -47.82% net margin. Recent FDA approval for Ryoncil potency assay and completion of Phase 3 back pain trial represent significant operational milestones. Cash position remains strong at $161.16 million, though debt levels require monitoring.
While MESO shows promising revenue growth and pipeline progress, persistent losses and negative ROE present fundamental challenges. Analyst consensus leans bullish with 45% buy ratings, but technical indicators suggest near-term caution. The stock offers speculative growth potential contingent on successful commercialization and path to profitability.
Occidental Petroleum (OXY) trades at $60.52, up 3.97% in the last session, with a bullish technical signal from moving averages. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $2.40 surpassing the $1.83 expectation. Financial health is supported by a strong net income margin of 30.32% and an ROE of 21.46%, though revenue has declined from $36.6B in 2022 to $21.6B in 2025. Analyst consensus is a Buy with a $71.40 price target, and a dividend of $0.28 is scheduled for payment in October 2026.
OXY presents a positive outlook driven by earnings beats, debt reduction efforts, and analyst optimism, but faces risks from volatile oil prices and declining revenue trends. Investment appeal hinges on execution of cash flow targets and oil market stability, with current valuation metrics like a P/E of 17.78 appearing reasonable relative to growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
